Perrigo Co. (PRGO), a manufacturer of over-the-counter and prescription pharmaceuticals, said it was the first to receive final approval from the U.S. Food and Drug Administration for its abbreviated new drug application for ibuprofen and phenylephrine hydrochloride tablets, 200 mg/10 mg (over-the-counter), the store brand equivalent to Advil Congestion Relief Tablets, 200 mg/10 mg. Perrigo may begin shipments of the product prior to the upcoming cough/cold/flu season.
Advil Congestion Relief Tablets, 200 mg/10 mg is indicated for the relief of sinus pressure, nasal swelling and congestion, and headache. Projected annual sales of the product are around $18 million.
Chairman, President and CEO Joseph C. Papa stated, "This approval further strengthens our leading store brand position and highlights our commitment to bringing new affordable products to the market."
For comments and feedback contact: editorial@rttnews.com
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.